2024-07-28 13:13:22 ET
Summary
- Pyxis Oncology exemplifies strong momentum in the healthcare sector, with small-cap biotechs leading the way in positive breakout conditions.
- MDA breakout research uses multiple variables to forecast price changes, emphasizing optimal trading conditions for strong gains.
- The biotech breakout signal has produced +19.4% returns in LABU bull fund, with prior gains of +78.8% last November in the last strongest signal.
- July market conditions are extremely positive for small-cap stocks, with momentum moving away from mega cap giants like Lilly in the healthcare sector.
- This selection comes from the MDA breakout analysis with seven years of live forward testing on Seeking Alpha.
Introduction
Read the full article on Seeking Alpha
For further details see:
July Breakout: Healthcare Biotechs In The Strongest Move Since November